About Excelsus Statistics
Excelsus Statistics is a company based in Montreal (Canada) founded in 2014 was acquired by Innovaderm in July 2022. Excelsus Statistics offers products and services including Dermatology Clinical Trials and Aesthetics Research. Excelsus Statistics operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Innovaderm
(Jul 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Excelsus Statistics
Excelsus Statistics offers a comprehensive portfolio of products and services, including Dermatology Clinical Trials and Aesthetics Research.
Conducts trials for skin conditions and treatments
Focuses on cosmetics and skin aging studies
Funding Insights of Excelsus Statistics
Detailed funding history for Excelsus Statistics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Excelsus Statistics
Excelsus Statistics has secured backing from 1 investor. Prominent investors backing the company include Innovaderm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Conducts clinical trials for dermatology research and patient care services.
|
Locked | Locked | Locked |
Investor details for Excelsus Statistics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Excelsus Statistics
Investment portfolio details for Excelsus Statistics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Excelsus Statistics
Detailed financials for Excelsus Statistics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Excelsus Statistics Comparisons
Peer comparison for Excelsus Statistics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Excelsus Statistics
Excelsus Statistics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO providing diversified clinical development services
|
|
| Locked | Locked | Locked |
Medicines and therapies are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
|
|
| Locked | Locked | Locked |
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
|
|
| Locked | Locked | Locked |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| Locked | Locked | Locked |
Serves as a contract research organization focused on drug clinical trials.
|
Detailed competitors of Excelsus Statistics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Excelsus Statistics
Complete news archive for Excelsus Statistics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Excelsus Statistics
Excelsus Statistics was founded in 2014.
Excelsus Statistics is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Excelsus Statistics was founded in 2014 and is headquartered in Montreal, Canada. Operations are centered on contract research organization services within the dermatology sector. Clinical development for dermatology drugs is managed, alongside site management and patient recruitment. Focus is placed on supporting pharmaceutical trials through these specialized activities in the North American market.
Excelsus Statistics's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.
Excelsus Statistics offers Dermatology Clinical Trials and Aesthetics Research.
Excelsus Statistics has 1 investor. Key investors include Innovaderm.